TLPPF
Price:
$13.4
Market Cap:
$6.81B
Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation (MTR) products for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company focuses on developing diagnostic and therapeutic products using MTR. Its lead products include TLX591-CDx for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX66-CDx to treat bone marrow conditioning and rare diseases; TLX250, which is in Phase II clinical trials for the diagnosis and treatment of renal (kidney) cancer; TLX250-CDx that is in Phase III clinical trials for the diagnosis and treatment of renal (kidney) cancer; TLX591, which is...[Read more]
Industry
Biotechnology
IPO Date
2019-07-25
Stock Exchange
PNK
Ticker
TLPPF
According to Telix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is 134.00. This represents a change of 58.56% compared to the average of 84.51 of the last 4 quarters.
The mean historical PE Ratio of Telix Pharmaceuticals Limited over the last ten years is -176.57. The current 134.00 PE Ratio has changed -7689.05% with respect to the historical average. Over the past ten years (40 quarters), TLPPF's PE Ratio was at its highest in in the June 2024 quarter at 138.22. The PE Ratio was at its lowest in in the March 2023 quarter at -64.17.
Average
-176.57
Median
-22.47
Minimum
-2094.80
Maximum
618.46
Discovering the peaks and valleys of Telix Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 83.57%
Maximum Annual PE Ratio = 618.46
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -2094.80
Year | PE Ratio | Change |
---|---|---|
2023 | 618.46 | -3093.36% |
2022 | -20.66 | -24.56% |
2021 | -27.39 | 22.58% |
2020 | -22.34 | 83.57% |
2019 | -12.17 | -46.11% |
2018 | -22.59 | -19.36% |
2017 | -28.01 | -98.66% |
2016 | -2094.80 | -Infinity% |
2015 | 0 | -100.00% |
2000 | -156.19 | -30.11% |
The current PE Ratio of Telix Pharmaceuticals Limited (TLPPF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
190.14
5-year avg
107.18
10-year avg
-176.57
Telix Pharmaceuticals Limited’s PE Ratio is greater than Genscript Biotech Corporation (-18.26), greater than Keros Therapeutics, Inc. (-12.88), greater than Zentalis Pharmaceuticals, Inc. (-1.36), greater than Innovent Biologics, Inc. (-28.70), greater than MAIA Biotechnology, Inc. (-2.28), greater than Graphite Bio, Inc. (-0.13), greater than Roivant Sciences Ltd. (1.79), greater than Field Trip Health & Wellness Ltd. (0), greater than Nautilus Biotechnology, Inc. (-4.59), greater than Arcellx, Inc. (-85.84), greater than Ventyx Biosciences, Inc. (-0.89), greater than Immunocore Holdings plc (-25.92), greater than Vaxcyte, Inc. (-25.11), greater than DICE Therapeutics, Inc. (-23.17),
Company | PE Ratio | Market cap |
---|---|---|
-18.26 | $3.22B | |
-12.88 | $2.25B | |
-1.36 | $265.23M | |
-28.70 | $7.47B | |
-2.28 | $68.85M | |
-0.13 | $185.19M | |
1.79 | $8.80B | |
0 | $3.71M | |
-4.59 | $322.70M | |
-85.84 | $4.65B | |
-0.89 | $151.94M | |
-25.92 | $1.56B | |
-25.11 | $12.97B | |
-23.17 | $2.27B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Telix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Telix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Telix Pharmaceuticals Limited's PE Ratio?
How is the PE Ratio calculated for Telix Pharmaceuticals Limited (TLPPF)?
What is the highest PE Ratio for Telix Pharmaceuticals Limited (TLPPF)?
What is the 3-year average PE Ratio for Telix Pharmaceuticals Limited (TLPPF)?
What is the 5-year average PE Ratio for Telix Pharmaceuticals Limited (TLPPF)?
How does the current PE Ratio for Telix Pharmaceuticals Limited (TLPPF) compare to its historical average?